Why the study?
The mechanisms underlying ARVC-associated cardiac arrhythmias remain poorly understood.
Population
Cardiac-specific integrin beta1D knockout mice and human left ventricular tissues from patients with ARVC
Comparison
Integrin beta1D loss vs controls
Design
Preclinical animal and in vitro translational study
Authors
Loading...
Should not change ARVC care; leaves open integrin β1D–RyR2 as a hypothesis-generating arrhythmic mechanism.
Integrin β1D deficiency represents a novel mechanism underlying the increased risk of ventricular arrhythmias in patients with ARVC through RyR2 dysfunction.
Wang et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: